Dr. Kudchadkar on the FDA Approval of Avelumab in Merkel Cell Carcinoma
0 ভিউ
• 07/17/23
0
0
বসান
administrator
সাবস্ক্রাইবার
Ragini Kudchadkar, MD, assistant professor, Department of Hematology and Medical Oncology, associate director, Hematology and Medical Oncology Fellowship Program-Clinical/Service, Emory University School of Medicine, discusses the FDA approval of avelumab for the treatment of patients with Merkel cell carcinoma.
আরো দেখুন
ফেসবুক মন্তব্য
SORT BY-
শীর্ষ মন্তব্য
-
সর্বশেষ মন্তব্য